PharMerica Has Returned 12.9% Since SmarTrend Recommendation (PMC)
Comtex SmarTrend(R) - Tue May 13, 9:48AM CDT
SmarTrend identified an Uptrend for PharMerica (NYSE
Amedisys (AMED) in Focus: Stock Moves 6.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue May 13, 8:18AM CDT
Amedisys Inc. (AMED) was a big mover last session, as the company saw its shares rise by roughly 9% on the day.
Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago PharMerica Is Down 4.0% (PMC)
Comtex SmarTrend(R) - Mon May 12, 7:41AM CDT
When PharMerica (NYSE
PharMerica to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
Business Wire - Fri May 09, 7:30AM CDT
PharMerica Corporation (NYSE
Uptrend Call Working As PharMerica Stock Rises 14.4% (PMC)
Comtex SmarTrend(R) - Fri May 02, 9:27AM CDT
SmarTrend identified an Uptrend for PharMerica (NYSE
PharMerica Reports First Quarter 2014 Results
Business Wire - Thu May 01, 7:01AM CDT
--Successfully Executing Strategic and Operational Initiatives to Drive Long-Term Growth and Value Creation
PharMerica Corporation Announces First Quarter 2014 Earnings Call and Webcast
Business Wire - Fri Apr 18, 7:30AM CDT
PharMerica Corporation (NYSE
Addus HomeCare (PAL) Crumbles: Stock Drops 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 8:15AM CDT
Addus HomeCare’s shares fell over 5% yesterday, breaking its one-month volatile trading range
RadNet (RDNT) in Focus: Stock Adds 8.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 7:37AM CDT
RadNet, Inc. was a big mover last session, as the company saw its shares rise more than 8% on the day.
Coverage Initiated on Amedisys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 9:30AM CDT
On Mar 27, 2014, we initiated coverage on Amedisys.
FDA Clears Quest Diagnostic's First HSV-1, 2 Detection Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 10:40AM CDT
Focus Diagnostics new Simplexa HSV 1 & 2 Direct molecular test on the 3M Integrated Cycler receives FDA approval
Can PharMerica (PMC) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:31AM CDT
PharMerica has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The Earnings ESP for PMC is positive, which is a great sign of a coming beat.
PharMerica Announces Date of 2014 Annual Meeting of Shareholders
Business Wire - Wed Mar 19, 7:00AM CDT
PharMerica Corporation (NYSE
NYSE stocks posting largest percentage increases
AP - Wed Mar 12, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Upgrade Alert for PharMerica (PMC)
Comtex SmarTrend(R) - Wed Mar 12, 7:07AM CDT
PharMerica (NYSE
PharMerica to Present at the Barclays Global Healthcare Conference
Business Wire - Mon Mar 10, 7:01AM CDT
PharMerica Corporation (NYSE
PharMerica Reports Fourth Quarter and Full Year 2013 Results
Business Wire - Fri Feb 28, 7:00AM CST
--Specialty Infusion and Oncology Businesses Expected to Generate Annual Revenues of Approximately $400 Million by 2016
IMBRUVICA(TM) Approved for Previously Treated Chronic Lymphocytic Leukemia; Immediately Available Through Onco360(R)
Business Wire - Thu Feb 13, 7:30AM CST
Onco360, the nation's fastest-growing independent Oncology Pharmacy and Clinical Support Services company, is proud to be part of the limited Specialty Pharmacy Network of IMBRUVICA(TM) (ibrutinib). IMBRUVICA(TM) is now also indicated for the treatment of patients with Chronic Lymphocytic Leukemia (CLL) who have received at least one prior therapy. This indication is based on overall response rate. An improvement in survival or disease-related symptoms has not been established.
Can Health Net (HNT) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 12:30PM CST
Health Net, Inc. is set to report fourth-quarter 2013 results on Feb 11.